Dr. Nair's research focuses on developing and applying non-invasive measurements of airway inflammation in the treatment of severe asthma and COPD. His laboratory characterizes the types of bronchitis in airway diseases using measurements in sputum, develops novel biomarkers in sputum, identifies mechanisms of bronchitis and explores novel targeted therapies of bronchitis. He directs the AllerGen National Centre of Excellence Clinical Investigators Consortium for Severe Asthma and is a co-investigator of the Canadian Respiratory Research Network. He was supported by the Canada Research Chair program from 2005-2015.

More information, including full agenda, here: https://sk.lung.ca/conference